NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









New Rhein Healthcare Investors

New Rhein Healthcare Investors

Philadelphia, Pennsylvanianewrhein.com

Overview

New Rhein Healthcare Investors is a venture capital firm that applies a private equity business model to life sciences investing, focusing on assets with proven clinical safety and efficacy. The firm takes significant stakes in a small number of companies and actively manages their value creation. It invests in pharmaceutical, healthcare, and medical device companies with clinical-stage assets across the United States and Europe. New Rhein invests broadly across all therapeutic areas, including Alzheimer's, respiratory disease, urology, and migraine.

Portfolio Companies

7

Investments

New Rhein Healthcare Investors investments
CompanyDateStageLead
Butterfly MedicalMay 2026Series CCo-investor
Alveus TherapeuticsFeb 2026Series A ExtensionLead
Alveus TherapeuticsJan 2026Series ALead
Corsair PharmaSep 2023Series BLead
American InjectablesSep 2022Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.